Congratulations to our clients Hint Health Inc. and their counsel Carrington Coleman Sloman & Blumenthal on the decisive verdict in U.S. District Court for the Eastern District of Texas on Sept. 30.
After a two-week jury trial in U.S. District Judge Amos Mazzant’s court, a panel of 8 jurors unanimously exonerated San Francisco-based Hint Health, a health tech startup, on all claims brought by Accresa, an Ameriflex company. Hint was represented by Carrington Coleman’s Alex More and Monica Latin.
“In true David vs. Goliath fashion, Hint’s defense turned back Accresa’s high-powered, high-priced legal team several times its size,” according to Hint’s press release about the verdict.
In July 2018, Accresa filed suit against Hint, claiming that the upstart company had stolen Accresa’s trade secrets and defrauded Accresa, among other allegations. Hint, a market leader since 2016, had developed cutting-edge technology on its own and jurors rejected Accresa’s claims of theft and fraud. While the jury did find that Hint had delayed testing of the companies’ software integration, the jury awarded $0 in damages to Accresa. The trial effectively ended over two years of hotly contested litigation between the two companies.
CourtroomLogic Consulting was proud to support Hint’s legal team with pre-trial strategy sessions, assistance with jury selection, and ongoing trial support.
The post Kudos to Hint Health and Carrington Coleman on ‘David vs. Goliath’ Win appeared first on CourtroomLogic.